首页> 美国卫生研究院文献>Biophysical Journal >Characterization of a Catalytic Ligand Bridging Metal Ions in Phosphodiesterases 4 and 5 by Molecular Dynamics Simulations and Hybrid Quantum Mechanical/Molecular Mechanical Calculations
【2h】

Characterization of a Catalytic Ligand Bridging Metal Ions in Phosphodiesterases 4 and 5 by Molecular Dynamics Simulations and Hybrid Quantum Mechanical/Molecular Mechanical Calculations

机译:分子动力学模拟和混合量子力学/分子力学计算表征磷酸二酯酶4和5中催化配体桥联金属离子

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Cyclic nucleotide phosphodiesterases (PDEs) constitute a large superfamily of enzymes regulating concentrations of intracellular second messengers cAMP and cGMP through PDE-catalyzed hydrolysis. Although three-dimensional x-ray crystal structures of PDE4 and PDE5 have been reported, it is uncertain whether a critical, second bridging ligand (BL2) in the active site is H2O or HO because hydrogen atoms cannot be determined by x-ray diffraction. The identity of BL2 is theoretically determined by performing molecular dynamics simulations and hybrid quantum mechanical/molecular mechanical (QM/MM) calculations, for the first time, on the protein structures resolved by x-ray diffraction. The computational results confirm our previous suggestion, which was based on QM calculations on a simplified active site model, that BL2 in PDE4 should be HO, rather than H2O, serving as the nucleophile to initialize the catalytic hydrolysis of cAMP. The molecular dynamics simulations and QM/MM calculations on PDE5 demonstrate for the first time that the BL2 in PDE5 should also be HO rather than H2O as proposed in recently published reports on the x-ray crystal structures, which serves as the nucleophile to initialize the PDE5-catalyzed hydrolysis of cGMP. These fundamental structural insights provide a rational basis for future structure-based drug design targeting PDEs.
机译:环核苷酸磷酸二酯酶(PDE)构成了一个大的酶超家族,通过PDE催化的水解作用调节细胞内第二信使cAMP和cGMP的浓度。尽管已报道了PDE4和PDE5的三维X射线晶体结构,但尚不确定活性位点中的关键第二桥键配体(BL2)是H2O还是HO -,因为氢原子不能由X射线衍射确定。 BL2的身份在理论上是通过对通过X射线衍射解析的蛋白质结构进行分子动力学模拟和混合量子力学/分子力学(QM / MM)计算首次确定的。计算结果证实了我们先前的建议,该建议基于简化的活性位点模型上的QM计算,即PDE4中的BL2应该是HO -而不是H2O,作为亲核试剂来初始化催化水解的cAMP。 PDE5上的分子动力学模拟和QM / MM计算首次证明,PDE5中的BL2也应为HO -,而不是最近发表的有关X射线晶体结构的报告中提出的H2O,它用作亲核试剂以初始化PDE5催化的cGMP水解。这些基本的结构见解为将来针对PDE的基于结构的药物设计提供了合理的基础。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号